000 01265 a2200361 4500
005 20250513104010.0
264 0 _c19970320
008 199703s 0 0 eng d
022 _a0195-668X
024 7 _a10.1093/oxfordjournals.eurheartj.a014706
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSimoons, M L
245 0 0 _aInterpretation of trials with drugs and devices; a double standard?
_h[electronic resource]
260 _bEuropean heart journal
_cOct 1996
300 _a1463-5 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAngioplasty, Balloon, Coronary
650 0 4 _aAnticholesteremic Agents
_xtherapeutic use
650 0 4 _aCoronary Artery Bypass
650 0 4 _aCoronary Disease
_xmortality
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPravastatin
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
_xstandards
650 0 4 _aScotland
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Outcome
773 0 _tEuropean heart journal
_gvol. 17
_gno. 10
_gp. 1463-5
856 4 0 _uhttps://doi.org/10.1093/oxfordjournals.eurheartj.a014706
_zAvailable from publisher's website
999 _c8902401
_d8902401